Case Study: Developing Health Systems Resources
Changing Diabetes in Pregnancy, Novo Nordisk
In 2009, Novo Nordisk initiated the Changing Diabetes in Pregnancy (CDiP) program in support of Millennium Development Goals 3 (promote gender equality and empower women) and 5 (improve maternal health).
The program’s overall goals are to:
- Change the future of diabetes for the next generation by improving diabetes-related maternal health during pregnancy, and
- Ensure a healthy pregnancy outcome and adequate postpartum follow-up, by promoting awareness and access to screening for and management of gestational diabetes (GDM).
The program is guided by three strategic objectives:
- Evidence gathering and advocacy
- Capacity building
- Support to local demonstration projects
The program focuses on pregnant women in low- and middle-income countries (and pregnant women from vulnerable groups in high-income countries, e.g., indigenous populations).
It is currently supporting projects in Colombia in partnership with the district government of Barranquilla and the World Diabetes Foundation and in Nicaragua in partnership with the World Diabetes Foundation, the Pan American Social Marketing Organisation (PASMO), and Population Services International (PSI).
Generally, awareness about GDM (and the increased risk of developing type 2 diabetes if it is not managed) is very poor in low- and middle-income countries. Increased attention on GDM seems to have a positive spillover effect on overall maternal care and diabetes awareness.
Additionally, to support awareness and screening activities on the ground, the CDiP program has supported the development of a health economic tool to assess the cost-effectiveness of GDM screening. The model, called “GeDiForCe,” is available free of charge.
Results to date?
- 3,578 healthcare providers trained
- 17,768 women screened for GDM
- 1,726 women with GDM diagnosed, treated, and educated
- 172,311 people reached through awareness campaigns
Related Case Studies on Developing Health Systems Resources
- Educating Healthcare Workers in Saudi Arabia, Roche
- Strengthening Diagnostics in Africa, Roche
- Changing Diabetes in Pregnancy, Novo Nordisk
- e-Learning to Reduce Maternal and Child Mortality, Novartis
- ColaLife, Johnson & Johnson
- Strengthening Healthcare Systems: 20 Percent Reinvestment Initiative, GSK
- Middle East Program in Health Economics and Health Technology Assessment, Bristol-Myers Squibb
- Changing Diabetes in Children, Novo Nordisk
- Transnet-Phelophepa Healthcare Train, Roche
- Alliance to Reduce Disparities in Diabetes, Merck
- Melanoma Exposed™. Screen. Protect. Know. Tell., Bristol-Myers Squibb
- Strengthening Healthcare Systems Through Investment in Community Health Workers, GlaxoSmithKline
- Takeda Initiative, Takeda Pharmaceutical Company Limited
- Jian Kang Kuai Che (“Health Express”), Novartis International AG